As part of the InPharma European Industrial Doctorate, all our early stage researchers (ESRs) will spend at least half of their projects in industry to provide them with a truly intersectoral and multidisciplinary training programme in the area of computational pharmaceutics and animal-free assessment methods in drug development.
Shaida Panbachi, ESR5, has recently completed her planned 18 months in academia where she was hosted by FHNW in Switzerland to come up with a novel DES-based formulation. As of 1st December 2022, Shaida is now starting her 18 month industrial secondment at Zentiva in Prague. The current plan is to study water as a critical quality attribute to the development of a novel DES formulation, to come up with further DES-based novel formulations, and to determine capsule compatability supported with in-vitro and in-vivo tests.
